How to keep innovating when roadblocks stand in your wayWith its position as one of the top 10 most–regulated industries in the US, pharma can pose a challenge to marketers eager Share XHow to keep innovating when roadblocks stand in your wayhttps://pharmaphorum.com/views-and-analysis/how-to-keep-innovating-when-roadblocks-stand-in-your-way/
Company profile: EvideraData disruption and applying ‘enabled intelligence’ to convert the promise shown in clinical trials into real-world success. For Share XCompany profile: Eviderahttps://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/data-disruption-and-applying-enabled-intelligence/
Pharma in the age of accelerationSyneos Health tracks the future paths for healthcare technology to identify what will be truly disruptive for the Share XPharma in the age of accelerationhttps://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/pharma-in-the-age-of-acceleration/
Opening doors in pharmaceutical developmentEvidera surveys the adoption of machine learning by the pharmaceutical industry and looks at how it can increase Share XOpening doors in pharmaceutical developmenthttps://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/machine-learning-opening-doors-in-pharmaceutical-development/
Novartis and Oxford University begin R&D tie-upNovartis and Oxford University have begun a partnership that will attempt to use artificial intelligence to predict how Share XNovartis and Oxford University begin R&D tie-uphttps://pharmaphorum.com/news/novartis-and-oxford-university-begin-rd-tie-up/
Deep Dive: Disruptive TechnologiesIn the first issue of Deep Dive for 2019, we look at disruptive technologies in pharma, how they’re Share XDeep Dive: Disruptive Technologieshttps://pharmaphorum.com/digital/disruptive-technologies-pharma-2019/
2018 in review: Alzheimer’s falters while oncology shinesGoing into 2018 you might have expected this to be the year of Alzheimer’s drugs, with several promising Share X2018 in review: Alzheimer’s falters while oncology shineshttps://pharmaphorum.com/r-d/views-analysis-r-d/2018-review-alzheimers-research-oncology/
2018 in review: AI on the rise in digital pharmaDigital technology is playing an increasingly important role in healthcare, and in the pharma industry as it searches Share X2018 in review: AI on the rise in digital pharmahttps://pharmaphorum.com/views-analysis-digital/2018-digital-review-ai-on-the-rise-in-pharma/
Disrupt or be disrupted, experts warn pharmaPharma is playing catch-up with digital technology – but in this age of big data and AI, there Share XDisrupt or be disrupted, experts warn pharmahttps://pharmaphorum.com/views-analysis-sales-marketing/disrupt-disrupted-experts-warn-pharma/
